Trade Summary

1 month ago, Lamattina John L, serving as Dir at Ligand Pharmaceuticals Inc (LGND), sold 2,161 shares at $200.76 per share, for a total transaction value of $433,842.00. Following this transaction, Lamattina John L now holds 30,724 shares of LGND.

This sale represents a 7.00% decrease in Lamattina John L's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, March 6, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 31, 2026, 25 days after the trade was made.

Ligand Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.